Holen Sie sich die Stockscreener-App
36.34
3.47%
1.22
Roivant Sciences Ltd Aktie (ROIV) Neueste Nachrichten
Roivant Sciences Ltd (ROIV) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Roivant Sciences (ROIV) affiliate files to sell 200,000 common shares after option exercise - Stock Titan
Roivant Sciences Ltd. Revenue Breakdown – SWB:87S - TradingView
Immunovant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026 - marketscreener.com
Roivant Sciences Ltd (ROIV) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Roivant Sciences Ltd (ROIV) Income Statement - TradingKey
ROIV|Roivant Sciences Ltd|Price:34.710|Chg%:-0.300 - TradingKey
TradingKey - TradingKey
Roivant Sciences Ltd (ROIV) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Roivant Sciences Ltd. Revenue Breakdown – TRADEGATE:87S - TradingView
ROIV|Roivant Sciences Ltd|Price:35.010|Chg%:-0.090 - TradingKey
Dimensional Fund Advisors LP Sells 1,771,602 Shares of Roivant Sciences Ltd. $ROIV - MarketBeat
Roivant Sciences Ltd. (ROIV) Stock Price, News, Quote & History - Yahoo! Finance Canada
Bank of Nova Scotia Cuts Stake in Roivant Sciences Ltd. $ROIV - MarketBeat
Allspring Global Investments Holdings LLC Buys New Stake in Roivant Sciences Ltd. $ROIV - MarketBeat
ROIV Stock Nears Record High –Retail Traders See Breakout After Surprise Earnings Beat - Stocktwits
Roivant Sciences Ltd. (ROIV) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Roivant Sciences (ROIV) Edges Lower as Stock Consolidates Near Support ZoneInsider Sentiment - dars.gov.et
Roivant Sciences Ltd. (NASDAQ:ROIV) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
California Public Employees Retirement System Invests $19.15 Million in Roivant Sciences Ltd. $ROIV - MarketBeat
Roivant Sciences Ltd. (ROIV) stock price, news, quote and history - Yahoo Finance UK
Roivant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026 - marketscreener.com
Baader Bank Aktiengesellschaft Sells 33,612 Shares of Roivant Sciences Ltd. $ROIV - MarketBeat
Roivant to report Q1 results, host conference call and webcast - Bitget
Immunovant (NASDAQ: IMVT) plans 2026 votes on directors, auditor and pay - Stock Titan
Roivant Sciences Holds Steady Near $35 Amid Measured TradingAI Trade Signals - dars.gov.et
Roivant Sciences Ltd. (ROIV) Stock forecasts - Yahoo Finance UK
Bank of New York Mellon Corp Decreases Stock Holdings in Roivant Sciences Ltd. $ROIV - MarketBeat
Form 4 Roivant Sciences Ltd. For: 21 July By Investing.com - Investing.com Nigeria
Form 4 Roivant Sciences Ltd. For: 21 July - Investing.com India
Roivant Sciences (ROIV) grants director Oren Ilan 775 fully vested shares - Stock Titan
Responsive Playbooks and the ROIV Inflection - Stock Traders Daily
Illinois Municipal Retirement Fund Boosts Stake in Roivant Sciences Ltd. $ROIV - MarketBeat
Roivant Sciences Ltd. (ROIV) Stock Analysis: Exploring a 13.93% Upside in Biotech Innovation - DirectorsTalk Interviews
Why is Billionaire Joe Edelman Bullish on Roivant Sciences (ROIV) - Kavout | AI
Pfizer, BioNTech face global patent suits from Arbutus, Roivant over COVID vaccine tech - Seeking Alpha
Roivant Sciences Ltd. (ROIV) Stock Analysis: Exploring the 9.47% Upside Potential in Biotech Innovation - DirectorsTalk Interviews
Roivant Sciences (ROIV) Goldman Sachs 47th Annual Global Healthcare Conference 2026 summary - Quartr
Candriam S.C.A. Lowers Position in Roivant Sciences Ltd. $ROIV - MarketBeat
Roivant’s Gline: From spin-cos to commercial conviction - BioCentury
Roivant Sciences (ROIV) Climbs 2%: Biotech Stock Tests Key Resistance Near $38.65Moving Average Ribbon - dars.gov.et
Roivant Sciences (ROIV) TD Cowen 45th Annual Healthcare Conference Summary - Quartr
Roivant Sciences stock hits all-time high at 35.92 USD By Investing.com - Investing.com Nigeria
Roivant Sciences stock hits all-time high at 35.92 USD - Investing.com
Could Roivant Sciences Be a Multibagger Stock Over the Next 5 Years? - Yahoo Finance
Roivant Sciences Ltd. (ROIV) Stock Analysis: Potential Upside Amidst Biotech Innovations - DirectorsTalk Interviews
If You Invested $1,000 in Roivant Sciences (ROIV) - Stock Titan
ROIVRoivant Sciences Ltd Dividends - Finviz
Roivant Sciences Insider Sold Shares Worth $610,252, According to a Recent SEC Filing - Moomoo
Roivant Sciences (ROIV) director exercises options, sells 10,000 common shares - Stock Titan
Roivant Sciences (ROIV) Edges Lower, Consolidating Between Key Support and Resistance LevelsRegression Channel - dars.gov.et
Roivant Sciences (ROIV) Left Key Russell Indexes, Is It Still 10% Below Fair Value? - simplywall.st
Roivant Sciences (ROIV) director sells 17,750 shares after exercising options - Stock Titan
Roivant Sciences Insider Sold Shares Worth $56,444,076, According to a Recent SEC Filing - marketscreener.com
Roivant Sciences Insider Sold Shares Worth $49,354,076, According to a Recent SEC Filing - marketscreener.com
Roivant Sciences (ROIV) director-linked entity reports 1.44M-share open-market sale - Stock Titan
0.86%
1.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):